LINC02137

Across TCGA pan-cancer cohorts, LINC02137 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02137 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02137 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02137 expression acts as an unfavorable survival marker, although some lineages such as ACC and LUSC show a favorable association.

ACC, LUSC, and LIHC are the cancer types where LINC02137 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.838	0.400	<.001	88	view →
LUSC	DFS	Quartile	All	0.742	0.555	<.001	64	view →
LIHC	OS	Quartile	III,IV	0.299	0.720	<.001	46	view →
HNSC	DFS	Median	III,IV	0.646	0.481	<.001	44	view →
KICH	DFS	Median	III,IV	0.409	1.000	.002	36	view →
COAD	DFS	Quartile	II,III,IV	0.225	0.678	<.001	33	view →
KIRC	DFS	Tertile	All	0.568	0.704	.004	27	view →
KIRP	OS	Median	III,IV	0.656	0.931	.008	24	view →
SKCM	OS	Tertile	II,III,IV	0.736	0.913	.005	22	view →
BLCA	DFS	Quartile	IV	0.063	0.420	.002	19	view →
READ	DFS	Tertile	IV	0.371	0.738	.009	15	view →
GBM	DFS	Quartile	All	0.342	0.212	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC02137–ACC (OS)

Open the ACC breakdown →